top of page
Psychology Session
Psychology Session
NYU Logo.JPG
NKI_LOGO.jpg

Depression treatment and Aß dynamics: A study of Alzheimer’s disease risk
(ABD Study)

The purpose of this research study is to test if a reduction in depressive symptoms in response to treatment with an antidepressant improves levels of certain proteins which have been associated with increased risk for the development of Alzheimer's disease (AD). This study will be conducted at New York University Langone Health (NYULH) or Nathan Kline Institute (NKI), and we expect a total of about 150 subjects age 60+ to enroll in the study across the 2 sites to reach a goal of 90 randomized subjects.

For more information, contact Dr. Antero Sarreal, Study Coordinator, 845-398-6532 or asarreal@nki.rfmh.org

140 Old Orangeburg Road, Building 35, Orangeburg, New York 10962 845-398-5582

bottom of page